SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.96    0.16 (1.82%)
Bid:
8.44
Ask:
8.98
Spread: 0.54 (6.398%)
Market Cap: $959.06m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

Intended conversion of MHP S.A.

23 Jun 2017 07:21

RNS Number : 9876I
MHP S.A.
23 June 2017
 

 

PRESS RELEASE

June 23, 2017, Kyiv, Ukraine

MHP S.A.

Intended conversion of MHP S.A. from Société Anonyme to Societas Europaea

MHP S.A., a Luxembourg registered public limited liability company (société anonyme) with registered office at 5, rue Guillaume Kroll, L-1882 Luxembourg, one of the leading agro-industrial companies in Ukraine, announces that on June 22, 2017 the board of directors of the Company (the "Board") resolved to submit for approval of shareholders at an extraordinary general meeting a proposal to convert the Company from a Luxembourg Société Anonyme ("S.A.") into a European Company, or Societas Europaea ("SE") (the "Conversion") .

This is the first step towards the possible transfer of the Company's registered office to another location within the EU to enable simplification of the group's legal structure.

It is planned to implement the Conversion in accordance with article 31-2 of the Luxembourg law of August 10, 1915 on commercial companies, as amended (the "Company Law") and article 37 of the Council Regulation (EC) No 2157/2001 of October 8, 2001 on the Statute for a European company (SE) (the "SE Regulation"), such that the Company will be renamed "MHP SE", and the Company's articles of association will be amended to comply with the relevant SE legal provisions. Upon Conversion, the registered office of the Company will remain in Luxembourg, at its current address. The Conversion will have no effect on the Company's share capital which will remain at EUR 221,540,000 represented by 110,770,000 shares with a nominal value of EUR 2 each.

In accordance with the Company Law and the SE Regulation, the Board has approved (i) draft terms of the contemplated Conversion, which will be published in the Luxembourg Recueil Electronique des Sociétés et Associations and (ii) a board report explaining and justifying the legal and economic grounds of the Conversion and indicating the consequences of the Conversion for the Company's shareholders and employees. In accordance with the Company Law and the SE Regulation, the Board has appointed an expert ("réviseur d'entreprises agréé") to certify that the Company has net assets at least equivalent to its capital plus reserves which may not be distributed under the law or by virtue of the Company's articles of association.

The Conversion will provide the Company with a legal framework which is recognized in each of the European Union Member States. This will allow the Company's shareholders to transfer its registered office freely (subject to the applicable legal provisions) to any other place within the European Union without having to liquidate the Company or create a new legal entity.

Implementation of the Conversion is conditional upon all resolutions required to implement the Conversion, as set out in the notice of the extraordinary general meeting of shareholders, being duly passed.

 

Please address any questions or concerns to:

Anastasiia Sobotiuk (Kyiv)

Director of IR & Company Secretary

 

+38 044 207 00 70

+38 050 339 29 99

a.sobotyuk@mhp.com.ua

John Grant (London)

Senior Independent Director

+44 (0)7768 465042

johngrant13@btconnect.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKKDAFDXEEF
Date   Source Headline
1st Jun 20267:00 amRNSMHP SE to acquire up to 100% of Th. Nitsiakos AVEE
8th May 20267:34 amRNSMHP SE Notice of Annual General Meeting
5th May 20267:04 amRNSFinancial Results for the Q4 and 12M
17th Feb 20261:10 pmRNSMHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT
13th Feb 20269:34 amRNSMHP LUX S.A. ANNOUNCES RESULTS OF TENDER OFFER
10th Feb 202610:32 amRNSMHP SE TAP OFFERING CLOSING ANNOUNCEMENT
4th Feb 20267:00 amRNSMHP Tap Pricing Announcement
3rd Feb 20269:11 amRNSMHP Tap Launch Announcement
28th Jan 202611:21 amRNSMHP NEW EUROBOND CLOSING ANNOUNCEMENT
22nd Jan 20267:00 amRNSMHP SE - Eurobond 2026 - Pricing Announcement
15th Jan 20261:28 pmRNSMHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT
15th Jan 20261:12 pmRNSMHP SE NEW EUROBOND MANDATE AND TENDER OFFER
15th Jan 202612:57 pmRNSMHP LUX S.A. - INVITATION TO PURCHASE NOTES
15th Dec 20257:00 amRNSMHP SE Financial Results for the Q3 and 9 M 2025
9th Dec 20252:07 pmRNSMHP SE Results of EGM 09 December 2025
14th Nov 20252:14 pmRNSNotification about GDRs Purchase by PDMR of MHP
7th Nov 20258:25 amRNSConvening Notice of Extraordinary General Meeting
12th Sep 20257:00 amRNSFinancial Results for the Q2 and 6M 2025
4th Aug 20257:00 amRNSMHP Closes Acquisition of 92% Stake in Grupo UVESA
16th Jun 20251:39 pmRNSMHP SE Results of AGM 2025
21st May 20257:00 amRNSFinancial Results for the First Quarter 2025
14th May 20258:58 amRNSNotice of Annual General Meeting 2025
28th Apr 20257:09 amRNSFinancial Results Q4 and 12M 2024
28th Apr 20257:00 amRNSMHP acquires 91.77% of UVESA
21st Mar 20257:00 amRNSMHP signs Share Purchase Agreement with UVESA
11th Dec 20247:00 amRNSMHP offers to acquire UVESA Group
10th Dec 20241:08 pmRNSPress release on EGM result
22nd Nov 20247:10 amRNSFinancial Results for Q3 and 9M 2024
5th Nov 202411:33 amRNSNotice of Extraordinary General Meeting
17th Sep 202412:31 pmRNSDisclosure Notification
6th Sep 20249:29 amRNSFinancial Results for Q2 and 6M 2024 replace
19th Jun 202410:34 amRNSResults of AGM
4th Jun 20247:37 amRNSFinancial Results for the First Quarter 2024
17th May 20248:47 amRNSConvening Notice - AGM 2024
17th May 20247:22 amRNSBoard Changes
10th May 20247:58 amRNS2024 Eurobond Repayment
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.